Treatment matched to individual biology: genomic profiling, biomarkers and the platforms making patient-specific medicine practical.
69 articles
Oxford Nanopore’s recently released data shows that although a significant advancement in nanopore based sensing technologies, it is still not ready for use in laboratories...
Engineers at the University of Washington synthesized nanoparticles using an engineered protein to improve vaccine production and administration. Moving from attenuated or killed pathogens to...
23andMe, a personal genome sequencing service company has been directed by the Food and Drug Administration (FDA) to desist from selling its genetic test kits...
Graphene based Nanopores may be the technological leap that researchers have been looking for achieving reduced error rates in solid state nanopore sequencing. Researchers at...
Researchers from University of Toronto’s Institute of Biomaterials and Biomedical Engineering (IBBME) have developed a new tumour-on-a-chip microfluidics screening platform for predicting the behaviour of nanoparticles...
EKF Molecular, a part of EKF Diagnostics Holdings plc, is the provider of highly specific, sensitive and innovative technologies and products for molecular diagnostics to...
DNA Spectrum, a DNA profiling company has introduced a new myDNA Safe secure DNA storage system that allows individuals to store their genome over a...
Integrated DNA Technologies (IDT) has launched the first next generation sequencing product for cancer. The xGen Acute Myeloid Leukaemia Cancer Panel has 11,743 xGen Lockdown...
